{"id":"W2045058534","doi":"10.1158/0008-5472.sabcs10-p3-14-07","title":"Abstract P3-14-07: A Phase 1 Study To Assess the Safety, Tolerability and PK of ARRY-380 — An Oral HER2 Inhibitor","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Cmax; Nausea; Tolerability; Rash; Dosing; Adverse effect; Lapatinib; Trastuzumab; Internal medicine; Pharmacokinetics; Gastroenterology; Pharmacology; Cancer; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001800116,0.001708477,0.002054419,0.0004054433,0.0005400667,0.000941887,0.001271728,0.001331796,0.004300211],"category_scores_gemma":[0.0007549609,0.0006596882,0.000861739,0.0004260238,0.001164992,0.001041743,0.0003777457,0.004758975,0.001520691],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001275764,"about_ca_system_score_gemma":0.002890147,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001458201,"about_ca_topic_score_gemma":0.002401478,"domain_scores_codex":[0.9995208,0.0001881564,0.00002201369,0.00008998418,0.00007145936,0.0001074989],"domain_scores_gemma":[0.9993767,0.00008027536,0.00009242387,0.00006074256,0.00004578927,0.0003441215],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3552044,0.2075588,0.01058084,0.001150207,0.001449334,0.001339904,0.0006207704,0.005017422,0.2422313,0.0007085372,0.01818254,0.155956],"study_design_scores_gemma":[0.2709309,0.6925709,0.01244272,0.00003432007,0.0003188996,0.001333443,0.00007188423,0.002581347,0.01436866,0.0003570525,0.004941704,0.00004804751],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917564,0.0009997524,0.0009723352,0.0004022679,0.00006441258,0.002343007,0.001405857,0.0002084815,0.001847452],"genre_scores_gemma":[0.9791702,0.001341117,0.004464957,0.001248317,0.0001435617,0.003560404,0.005393052,0.000114294,0.004564087],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004300211,"threshold_uncertainty_score":0.01438564,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2525772356432266,"score_gpt":0.5622187609640096,"score_spread":0.309641525320783,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}